CardioLogs ECG Analysis Platform

by Cardiologs Technologies (now part of Philips)  · Based in France → — Reinventing cardiology diagnostics with medical-grade AI and cloud technology.
Cardiology Emergency Medicine Internal Medicine

Contact sales for customized quote
Regulatory Status Disclosed

Overview

The Cardiologs ECG Analysis Platform, now part of Philips, is a medical-grade artificial intelligence and cloud-based solution designed to transform cardiac diagnostics. It leverages deep neural network (DNN) technology to analyze electrocardiogram (ECG) waveforms, mimicking human brain function to handle complex ECG patterns more effectively than traditional algorithms. The platform aims to empower healthcare professionals by streamlining ECG analysis, accelerating diagnostic reporting, and reducing the burden of redundant tasks. It is vendor-neutral, compatible with various cardiac monitoring devices such as Holter monitors, smartwatches, and ECG patches, and provides supportive information for physicians in assessing arrhythmias. The system is built on a continuously growing database of millions of ECG recordings and is supported by numerous clinical publications.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-Powered ECG Analysis (Deep Neural Networks)
  • Cloud-Based Platform
  • Multi-Device Compatibility (Holter, smartwatches, ECG patches)
  • Automated Arrhythmia Detection (e.g., AFib, VT)
  • Customizable Reports
  • Integration with EHR Systems
  • Real-Time Monitoring/Analysis
  • Data Encryption & Secure Hosting (ISO/IEC 27001 certified AWS servers)
  • User-Friendly Interface
  • Data Export Options

Use Cases

  • Screening for Atrial Fibrillation (AFib) and other cardiac arrhythmias
  • Long-term ambulatory ECG monitoring and analysis
  • Reducing Holter analysis time and improving workflow efficiency
  • Supporting physicians in ECG interpretation and diagnosis
  • Remote patient monitoring (RPM) with smartwatch ECG data
  • Cardiac safety monitoring (e.g., for drug-induced cardiotoxicity)

What Physicians Need to Know

ECG/EKG Analysis Capability
The platform offers comprehensive ECG signal processing and analysis, including QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis. It leverages deep neural network (DNN) technology to analyze ECG waveforms, designed to mimic human expert interpretation, and is particularly effective for long-term ambulatory ECG recordings.
Arrhythmia Detection Accuracy
CardioLogs demonstrates high accuracy in arrhythmia detection. For Atrial Fibrillation (AFib), it boasts a 97% sensitivity and a 91% positive predictive value (PPV), outperforming conventional methods. It significantly reduces AF false positives by a factor of 10 in Holter analysis, improving specificity from 17.2% to 1.5%. The platform can detect over 20 types of cardiac events, including various AV blocks, AFib/Flutter, Ventricular Tachycardia, Premature Ventricular Complexes (PVCs), Premature Supraventricular Complexes (PSVCs), and rhythm abnormalities. Studies also indicate its deep learning AI surpasses the Apple Watch ECG algorithm in detecting atrial arrhythmias, increasing sensitivity by 34% and nearly eliminating inconclusive readings.
Real-Time Alert Capability
While the platform streamlines data review and allows physicians to leverage cardiac data for timely treatment decisions, it is explicitly stated that the CardioLogs ECG Analysis Platform is not intended for use in life-supporting or sustaining systems or as an ECG monitor and alarm device. However, its Remote Patient Monitoring (RPM) platform is designed to prioritize data requiring immediate attention.
Cardiac Monitoring Integration
The platform is device-agnostic and compatible with ECG data from a wide range of cardiac monitoring devices, including Holter monitors, event recorders, 12-lead ambulatory ECG devices, smartwatches, and ECG patches from multiple vendors. It supports electronic interfacing with other computer-based ECG management systems and offers an Application Programming Interface (API) for broader system integration.
AHA/ACC Guideline Alignment
The platform's utility in screening for AFib aligns with guideline recommendations, particularly for individuals over 65, acknowledging AFib's association with significant cardiovascular risks. References to the 2014 AHA/ACC/HRS guideline for atrial fibrillation management indicate its development and application consider established clinical guidelines.
Physician Tip

Leverage CardioLogs for efficient and accurate analysis of long-term ambulatory ECGs, particularly for arrhythmia detection like AFib, given its high sensitivity and significantly reduced false positives. Utilize its cloud-based access for flexible workflow and collaboration. Remember that the platform serves as an advisory tool to support clinical judgment, not as a standalone diagnostic. Its ability to process data from various monitoring devices can streamline your diagnostic pathway for a diverse patient population.

CardioLogs is designed for broad compatibility, offering vendor-neutral integration with numerous ECG recording devices (Holters, smartwatches, patches, 12-lead ambulatory ECGs). Its cloud-based architecture facilitates seamless data upload and access from any internet-connected computer. The availability of an API allows for integration into existing ECG management systems and other computerized ECG monitoring devices, enhancing workflow efficiency across different healthcare settings.

Details

Category Cardiology AI
Pricing Contact sales for customized quote — Pay per ECG regardless of the number of users.
DeploymentCloud-based (SaaS)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Cardiologs ECG Analysis Platform received FDA clearance (K170568) on June 26, 2017, for the assessment of arrhythmias using ECG data in subjects over 18 years of age. The Cardiologs Holter Platform also received FDA clearance (K212112) on January 13, 2022, for use in both adult and pediatric populations.

Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

What the Web Says

CardioLogs ECG Analysis Platform is a cloud-based, AI-powered solution designed to streamline and improve the accuracy of ECG interpretation for healthcare professionals. It utilizes deep neural networks to analyze ECG data, aiming to reduce the burden of manual analysis and enhance the detection of various arrhythmias, including atrial fibrillation (AFib). The platform is FDA-cleared and CE-marked, and it is compatible with multiple recording devices, offering flexibility and remote access for clinicians.

Overall: Positive

Strengths

  • Reduces ECG analysis time significantly (e.g., 26.6% to 42% reduction in Holter analysis time).
  • Improved sensitivity for detecting certain arrhythmias like AFib and ventricular tachycardia compared to conventional methods.
  • Cloud-based access allows for frequent automatic updates, remote access, and collaboration among multiple users.
  • Vendor-neutral solution, compatible with various recording formats and devices (Holter, event recorder, smartwatches, ECG patches).
  • Utilizes clinically validated AI (deep neural networks) built on a large database of ECG recordings.
  • Helps alleviate the burden of redundant ECG analysis tasks and can generate easy-to-read, enriched reports.

Limitations

  • Some general concerns exist regarding AI in medical technologies, including potential apprehension about errors and the need for human control.
  • The platform's interpretation results are advisory and not intended to be the sole means of diagnosis, requiring physician oversight.
  • While AI improves accuracy, some studies on similar AI ECG tools suggest they may require longer interpretation times compared to experienced clinicians, and results should be interpreted cautiously with small datasets.
  • Limited independent user reviews available on platforms like G2 and Capterra specifically for the CardioLogs ECG Analysis Platform.
  • The cost of enterprise-level AI solutions can be very expensive.
  • Some Reddit discussions about AI ECG tools highlight that existing algorithms in ECG devices are already good, posing a competitive challenge for new AI solutions.

Based on reviews from: Philips, Evaluation of an Ambulatory ECG Analysis Platform Using Deep Neural Networks in Routine Clinical Practice, SoftwareSuggest, DAIC, accessdata.fda.gov, tctmd.com, G2, Reddit, Partech, MedTech Dive

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CardioLogs ECG Analysis Platform

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Medical Device Network
Cardiologs Technologies receives FDA approval for ECG Analysis Platform
France-based Cardiologs Technologies secured FDA approval for its cloud-based, AI-powered Cardiologs ECG Analysis Platform, designed to help physicians screen for atrial fibrillation and other arrhythmias. The system leverages a neural network trained on over 500,000 ECG recordings.
2017-07
DAIC
Cardiologs ECG Analysis Platform Receives FDA Clearance
Cardiologs Technologies SAS announced FDA clearance for its AI-powered Cardiologs ECG Analysis Platform, a cloud-based service for detecting atrial fibrillation and other arrhythmias from long-term ambulatory ECG recordings. The platform also holds CE mark in Europe.
2017-07
Cardiac Rhythm News
US FDA clears Cardiologs ECG Analysis platform
Cardiologs Technologies SAS received US FDA clearance for its AI-powered ECG Analysis platform, a cloud-based service for screening atrial fibrillation and other arrhythmias using ambulatory ECG recordings. The platform's sensitivity for AF detection was reported at 97% and positive predictive value at 91%.
2017-07
PR Newswire
Cardiologs Announces Clinical Study to Monitor Cardiac Safety of COVID-19 Patients Via Smartwatches
Cardiologs launched a clinical study to remotely monitor the cardiac safety of COVID-19 patients undergoing hydroxychloroquine treatment using its AI-based ECG analysis platform and smartwatch data. The platform is CE-Marked and FDA cleared for arrhythmia diagnostics and QT interval analysis.
2020-04
BMJ Health & Care Informatics
How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices
This article analyzes FDA-approved machine learning medical devices, including the Cardiologs ECG Analysis Platform (K170568), examining how these algorithms support clinician decision-making in tasks like diagnosis and triage. Most approvals for such devices have occurred since 2018.
2021-04
Medium (Cardiologs)
Real-life application of Artificial Intelligence for ECG analysis - Cardiologs
This article discusses the application of deep neural networks to ECG analysis, highlighting how the Cardiologs Platform uses an interpretable machine learning-based AI algorithm to improve arrhythmia detection. The platform is a Class IIa medical device in Europe and Class II in the USA.
2021-04
European Heart Journal - Digital Health
The inclusion of a Holter Reading software in the clinical practice of cardiology shows a multi-level high positive impact in healthcare: a real-world implementation study in three Spanish hospitals
A study in three Spanish hospitals evaluated the Cardiologs Holter analysis platform, an AI-based software from Philips, finding excellent concordance with cardiologists in detecting arrhythmias like atrial fibrillation, ventricular extrasystoles, and sinus pauses. The software is designed to interpret entire ECGs based on over 20 million recordings.
2025-05
Paubox
How adversarial AI threatens healthcare security systems
This article discusses the threat of adversarial AI to healthcare security systems, citing the Cardiologs ECG Analysis Platform as an example of an emergency diagnostic tool where a successful attack could lead to fatal medical errors. The research highlights systematic vulnerabilities in ML-enabled medical devices.
2025-08

Videos

Product demos, reviews, and walkthroughs for CardioLogs ECG Analysis Platform.

View all on YouTube

No FAQs available yet for this tool.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.